Lessons Learned on Data Privacy From Pharmaceutical Marketers

Posted on by Chief Marketer Staff

As brands explore alternatives to third-party cookies, which have long facilitated ad targeting, user tracking and personalization online, marketers can take a page from the pharmaceutical industry—a sector with years of experience complying to privacy regulations, according to a column in AdExchanger.

The approach entails connecting media marketing efforts more directly to ROI through building new data frameworks—leveraging statistics software and AI—that illustrate a more probabilistic customer journey, writes Mark Sturino, VP of Data and Analytics for Good Apple.

“Cookie replacement solutions connecting first-party data to individual ads through universal IDs are coming, but rather than chasing a retooled version of a historically clunky solution, marketers should build new data frameworks that employ statistical modeling and AI to illustrate a probabilistic media journey,” he says.

Though the KPIs will vary by industry, Sturino explains that marketers can consider media mixes segmented at the geographic level along with changes in budget, channel mix and messaging. And though the approach looks at data from population segments as opposed to individuals, the result could lead to a more established connection between media marketing efforts and ROI. For more on this approach, read on in AdExchanger.


Related Posts

Chief Marketer Videos

by Chief Marketer Staff

Check out this replay of crowning the winners of the 2022 Chief Marketer PRO Awards, which began with a lively conversation between two PRO Awards judges, Visible CMO Cheryl Gresham and Disney Parks’ Senior Manager, Multicultural Marketing, Angela Burgin Logan.


PRO Awards 2022

ProAwards 2022

Click here to view the 2022 Winners.


CM 200


Click here to view the 2023 winners!